EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson’s Disease

Linn Oftedal, Jodi Maple-Grødem, Ole-Bjørn Tysnes, Guido Alves, Johannes Lange

Journal of Parkinson’s Disease · 2023

DOI: 10.3233/jpd-230065 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2023. Verfasst von Linn Oftedal und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway. Hauptthemen laut MEDLINE: Parkinson Disease, Neurodegenerative Diseases, Alzheimer Disease. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Seed amplification assays (SAA) are the first credible molecular assay for Parkinson’s disease (PD). However, the value of SAA to support the clinicians’ initial diagnosis of PD is not clear. In our study, we analyzed cerebrospinal fluid samples from 121 PD patients recruited through population screening methods and taken within a median delay of 38 days from diagnosis and 51 normal controls without neurodegenerative disease. SAA yielded a sensitivity of 82.6% (95% CI, 74.7% – 88.9%) and specificity of 88.2% (95% CI, 76.1% – 95.6%). These results highlight the potential of SAA to support the initial diagnosis of PD in clinical practice and research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseNeurodegenerative DiseasesAlzheimer DiseaseHumansalpha-SynucleinBiomarkers

Stichwörter der Autor:innen

Parkinson’s diseaseSeed amplification assayalpha-synucleinbiomarkercerebrospinal fluiddiagnosis

Substanzen

alpha-SynucleinBiomarkers

Autor:innen und Institutionen

  • Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.
  • Department of Chemistry, Bioscience and Environmental Engineering, University of Stavanger, Stavanger, Norway.
  • Department of Neurology, Haukeland University Hospital, Bergen, Norway.
  • Department of Clinical Medicine, University of Bergen, Bergen, Norway.
  • Department of Neurology, Stavanger University Hospital, Stavanger, Norway.

Zitieren

APA

Oftedal, L., Maple-Grødem, J., Tysnes, O. B., Alves, G., & Lange, J. (2023). Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson’s Disease. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-230065

Vancouver

Oftedal L, Maple-Grødem J, Tysnes OB, Alves G, Lange J. Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson’s Disease. Journal of Parkinson’s Disease. 2023. doi:10.3233/jpd-230065

BibTeX
@article{Oftedal2023,
  author = {Oftedal, Linn and Maple-Grødem, Jodi and Tysnes, Ole-Bjørn and Alves, Guido and Lange, Johannes},
  title = {Seed Amplification Assay as a Diagnostic Tool in Newly-Diagnosed Parkinson’s Disease},
  journal = {Journal of Parkinson’s Disease},
  year = {2023},
  doi = {10.3233/jpd-230065}
}
Kostenlos starten →